Phillip Monk
Hoofd Techniek/Wetenschap/O&O bij SYNAIRGEN PLC
Vermogen: 32 910 $ op 30-04-2024
Profiel
Phillip David Monk is currently the Executive Director & Chief Scientific Officer at Synairgen Plc since 2009.
He is also currently a Director at Synairgen Research Ltd.
Additionally, he previously worked as the Director-Respiratory & Inflammation Biology Group at MedImmune Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SYNAIRGEN PLC
0.21% | 31-12-2022 | 423 934 ( 0.21% ) | 32 910 $ | 30-04-2024 |
Actieve functies van Phillip Monk
| Bedrijven | Functie | Begin |
|---|---|---|
| SYNAIRGEN PLC | Hoofd Techniek/Wetenschap/O&O | 03-09-2009 |
Synairgen Research Ltd.
 Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Directeur/Bestuurslid | 03-09-2009 |
Eerdere bekende functies van Phillip Monk
| Bedrijven | Functie | Einde |
|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SYNAIRGEN PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Synairgen Research Ltd.
Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Commercial Services |
